Prostate cancer is the second killer cancer of men after lung cancer. The disease affects the prostate glands. There is a new prostate cancer study which helps guide a patient's treatment through adding an interim scan during therapy: the use of 177Lu PSMA PET imaging for metastatic castration resistance cancer. After two cycles, the study showed improved predictive value on the survival of patients. The statistic about the interim scan;
• According to the National Cancer Institute (NIS), there is a 30.5 percent survival rate of prostate cancer patients five years after metastatic. The therapy indicates improved results since the use of PSMA PET scan determines patients who are eligible for treatment. It has shown high predictive value among lymphoma patients through 177Lu PSMA therapy. • A new retrospective study carried out in Klinikumrechts de isar hospital of patients who underwent Gallium-68- (68Ga) PSMA PET CT scan at baseline to determine the scan's effectiveness. The scan can evaluate the whole body for the tumor. The tumor is indicated by a change in PSMA avid tumor volume. Tumor response after two cycles of RLT showed survival rates. Lesions can also be included in determining disease progression. Advantages of the interim scan • The PSMA scan can identify the level of risk of prostate cancer. It can check whether cancer has spread to other body parts, unlike conventional imaging methods. • It helps doctors to select the most effective treatment option for the cancer patient. It gives physicians an avenue for checking tumor uniqueness and the spread of cancer. • It ensures early detection of cancer. The scan takes three days maximally. You are given intravenous injections to protect you against radioactivity, and then imaging is done twice to determine the risk of a prostate cancer diagnosis. The technology ensures earlier detection and treatment of the disease.
0 Comments
|
AuthorAs the founder and medical director of the Prostate Seed Institute Dr. Gregory A. Echt. His vision to provide the most modern treatment, non surgical treatments for prostate cancer in various locations throughout the Dallas-Fort Worth continues to succeed. Now date, he has made a therapy for prostate implantation seed at over 2,500 men, including urologists and oncologists. Archives
December 2019
Categories |